MDSAP Audit Allows Emerging Firm To Expand Internationally

 
• By Elizabeth Orr

Blood-collection technology firm Tasso has been recommended for certification by MDSAP. The international qualification is part of a push to offer the company’s technology in countries such as Australia and Canada, CEO Ben Casavant told Medtech Insight. 

The blood-collection technology developed by emerging medtech firm Tasso Inc. has broad appeal.

Not only do the device’s design and upper-arm placement reportedly cause far less pain than traditional blood draws, but it...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation